Literature DB >> 10207178

Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells.

J Müthing1, S Duvar, D Heitmann, F G Hanisch, U Neumann, G Lochnit, R Geyer, J Peter-Katalinic.   

Abstract

To investigate in detail the expression of glycosphingolipids (GSLs) on endothelial cells, 4.85 x 10(9) human umbilical vein endothelial cells (HUVECs) were cultivated in a 2 l bioreactor using microcarriers as a support for anchorage dependent growing cells. Neutral GSLs and gangliosides were isolated and their structures were determined by TLC immunostaining, fast atom bombardment-mass spectrometry (FAB-MS) of the native GSLs, and gas chromatography-electron impact mass spectrometry (GC-EIMS) of partially methylated alditol acetates. GbOse4Cer, GbOse3Cer, and LacCer, all carrying mainly C24- and C16-fatty acid beside C18-sphingosine, were detected as the major neutral GSLs (36%, 23%, and 15% of the total orcinol stain, respectively); GlcCer, nLcOse4Cer, and nLcOse6Cer were expressed to substantial minor amounts (9%, 12%, and 5% of the total orcinol stain, respectively). TLC immunostaining revealed the presence of lipid bound Lewisx antigen, whereas the isomeric Lewisa structure was detectable only in very low quantities. GM3(Neu5Ac) with C18-sphingosine was the major ganglioside constituting about 90% of the whole ganglioside fraction. The fatty acid composition was determined by GC-MS of fatty acid methyl esters, indicating the predominance of C24- and C16-substituted GM3(Neu5Ac), followed by C18- and C22-substituted species. Terminally alpha2-3 sialylated neolacto-series ganglioside IV3Neu5Ac-nLcOse4Cer was the second most abundant ganglioside in HUVECs (8% of the total resorcinol stain), and IV6Neu5Ac-nLcOse4Cer and VI3Neu5Ac-nLcOse6Cer (together less than 2% of total resorcinol stain) were found in minor quantities. Lipid bound sialyl Lewisx antigen with poly-N-acetyllactosaminyl chains, and traces of gangliotetraose-type gangliosides GM1 and GD1a were identified by TLC immunostaining. The expression of dominant neutral GSLs LacCer, GbOse3Cer, and GbOse4Cer, and of ganglioside GM3(Neu5Ac) was assayed by indirect immunofluorescence microscopy of cell layers grown in chamber slides, each showing different plasma membrane and subcellular distribution patterns. The complete structural characterization of GSLs from HUVECs contributes to our understanding about their functional role, not only of the carbohydrate but also of the lipid moiety, as receptors for bacterial toxins, as cell surface antigens of cellular interaction and as receptors for blood components and macromolecules of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207178     DOI: 10.1093/glycob/9.5.459

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  13 in total

1.  Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.

Authors:  Jing Huang; David G Motto; David R Bundle; J Evan Sadler
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.

Authors:  Christian H Schweppe; Petra Hoffmann; Jerzy-Roch Nofer; Gottfried Pohlentz; Michael Mormann; Helge Karch; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

3.  Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2.

Authors:  Marco Rusnati; Chiara Urbinati; Elena Tanghetti; Patrizia Dell'Era; Hugues Lortat-Jacob; Marco Presta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

4.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.

Authors:  Josefine Betz; Martina Bielaszewska; Andrea Thies; Hans-Ulrich Humpf; Klaus Dreisewerd; Helge Karch; Kwang S Kim; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-alpha stimulation.

Authors:  Tetsuya Okuda; Sin-ichi Nakakita; Ken-ichi Nakayama
Journal:  Glycoconj J       Date:  2010-02       Impact factor: 2.916

7.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

8.  Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.

Authors:  Purna Mukherjee; Anthony C Faber; Laura M Shelton; Rena C Baek; Thomas C Chiles; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-02-20       Impact factor: 5.922

9.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.

Authors:  Christian H Schweppe; Martina Bielaszewska; Gottfried Pohlentz; Alexander W Friedrich; Heino Büntemeyer; M Alexander Schmidt; Kwang S Kim; Jasna Peter-Katalinić; Helge Karch; Johannes Müthing
Journal:  Glycoconj J       Date:  2008-01-05       Impact factor: 2.916

10.  Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.

Authors:  Ariane Desselle; Tanguy Chaumette; Marie-Hélène Gaugler; Denis Cochonneau; Julien Fleurence; Nolwenn Dubois; Philippe Hulin; Jacques Aubry; Stéphane Birklé; François Paris
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.